Market intelligence is especially critical to sound pharmaceutical investing Pharmaceutical investing is both challenging and potentially very rewarding, but it requires understanding trends in the industry, including which drugs are…
How are drugs named, and how do names aid in prescription and generic substitution? In William Shakespeare’s play Romeo and Juliet, Juliet uses the phrase “A rose by any other name…
This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in Hickory, North Carolina and a member of the Alliance for…
How to Order the FDA Orange Book Historical copies of the FDA Orange Book archives are very potent tools for scholarly research and for litigation support, but until now there…
Dana Goldman, Anupam Jena, Posted with permission from STAT It’s hard not to like the notion of value-based pricing for prescription drugs. It aims to ensure that the prices we pay for…
One of the hottest-button political issues of the day is high prescription drug costs. On one side of the debate are politicians and patient groups espousing a populist viewpoint seeking…
Ed Silverman, Posted with permission from STAT Shortly before his company won the right last week to sell a new drug for severe eczema, Dr. Len Schleifer made a brash…
Rebecca Robbins, Posted with permission from STAT Plus When drug and device makers need a new chief medical officer or vice president, they often start by turning to executive recruiters. One…
Damian Garde, Posted with permission from STAT Has the age of the biotech blockbuster come to a close? Over the past year, a string of would-be best-sellers, expected to generate…
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food and Drug Administration recently released for naming both biologic medicines…